The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes

Main Article Content

Lailmah Javed
Yasir Ahmad
Salman Ullah Khan
Saad Binabiwaqas
Sumleen Khan

Abstract

Epidemiological data predicts a dramatic increase in the prevalence of diabetes and of diabetic retinopathy. The aim of the study it to assess the role of vitamin D in diabetic retinopathy. A descriptive cross-sectional study was carried out over the period of January 2021 to April 2021. Non-probability (Convenience) sampling was done by using a pre-prepared questionnaire. Two groups of patients were selected: 50 and 45 patients with and without retinopathy, respectively, as assessed by an experienced ophthalmologist. Subjects with advanced late diabetic complications were excluded to avoid confounding biases. Vitamin D concentrations and vitamin D deficiency was associated with the presence of diabetic retinopathy. Data was presented in the form of percentages, frequency and tables using the SPSS 26.0 for MacBook Pro. Patients with more advanced stages of retinopathy (grades 2–4) had lower concentrations of vitamin D and were more frequently vitamin D deficient as compared with patients not carrying this eye complication. To conclude, this study confirms that a positive correlation or association exists between vitamin D levels and the presence/severity of diabetic retinopathy in type 2 diabetes.

Article Details

How to Cite
Javed, L., Ahmad, Y., Khan, S. U., Binabiwaqas, S. ., & Khan, S. (2021). The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes. THE STETHO, 2(10). Retrieved from https://thestetho.com/index.php/ts/article/view/42
Section
Articles

References

Sherwin, R.; Jastreboff, A.M. Year in diabetes 2012: the diabetes tsunami.J. Clin. Endocrinol. Metab.2012,97,4293–430

D. Mauricio, T. Mandrup-Poulsen, and J. Nerup, “Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective,” Diabetes/Metabolism Reviews, vol. 12, no. 1, pp. 57–68, 1996.

X. Palomer, J. M. González-Clemente, F. Blanco-Vaca, and D. Mauricio, “Role of vitamin D in the pathogenesis of type 2 diabetes mellitus,” Diabetes, Obesity and Metabolism, vol. 10, no. 3, pp. 185–197, 2008.

C. Joergensen, P. Hovind, A. Schmedes, H.-H. Parving, and P. Rossing, “Vitamin D levels, microvascular complications, and mortality in type 1 diabetes,” Diabetes Care, vol. 34, no. 5, pp. 1081–1085, 2011.

C. Joergensen, H. Reinhard, A. Schmedes et al., “Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate,” Diabetes Care, vol. 35, no. 1, pp. 168–172, 2012.

Klein, B.E. Overview of epidemiologic studies of diabetic retinopathy.Ophthalmic Epidemiol.2007,14,179–183.

Zheng, Y.; He, M.; Congdon, N. The worldwide epidemic of diabetic retinopathy.Indian J. Ophthalmol.2012,60, 428–431.

Stratton, I.M.; Kohner, E.M.; Aldington, S.J.; Turner, R.C.; Holman, R.R.; Manley, S.E.; Matthews, D.R.UKPDS50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years fromdiagnosis.Diabetologia2001,44, 156–163.

Praidou, A.; Harris, M.; Niakas, D.; Labiris, G. Physical activity and its correlation to diabetic retinopathy.J. Diabetes Complicat.2017,31, 456–461.

N. Shimo, T. Yasuda, H. Kaneto et al., “Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients,” Diabetes Research and Clinical Practice, vol. 106, no. 2, pp. e41–e43, 2014.

H. Kaur, K. C. Donaghue, A. K. Chan et al., “Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes,” Diabetes Care, vol. 34, no. 6, pp. 1400–1402, 2011.

H. Ahmadieh, S. T. Azar, N. Lakkis, and A. Arabi, “Hypovitaminosis D in patients with type 2 diabetes mellitus: a relation to disease control and complications,” ISRN Endocrinology, vol. 2013, Article ID 641098, 7 pages, 2013.

K. Kienreich, A. Tomaschitz, N. Verheyen et al., “Vitamin D and cardiovascular disease,” Nutrients, vol. 5, no. 8, pp. 3005–3021, 2013.

I. Vinagre, M. Mata-Cases, E. Hermosilla et al., “Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain),” Diabetes Care, vol. 35, no. 4, pp. 774–779, 2012

M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher, “Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients,” Diabetes Care, vol. 29, no. 3, pp. 722–724, 2006.

Stitt, A.W.; Curtis, T.M.; Chen, M.; Medina, R.J.; McKay, G.J.; Jenkins, A.; Gardiner, T.A.; Lyons, T.J.;Hammes, H.P.; Simó, R.; et al. The progress in understanding and treatment of diabetic retinopathy.Prog. Retin. Eye Res.2016,51, 156–18